Brussels starts on March 1 with vaccine proposal from Novavax
In the Brussels-Capital Region, the new Novavax vaccine will be offered from 1 March in four vaccination centers, the joint community commission announced on Friday. Novavax’s vaccine is offered to people at high risk of allergic reactions to available corona vaccines, or to people who have experienced side effects from a first shot.
Novavax announced Friday that it has started supplying its vaccine – Nuvaxovid – in the European Union. It is a so-called protein vaccine, which works differently from the mRNA vaccines from Pfizer and Moderna. Because of this, it is possible to take a risk for the risks of previously used vaccines against COVID-19. People who need a first injection also come into appointments. Nuvaxovid also requires two doses, at least three weeks apart.
This new vaccine will be available in Brussels from 1 March, it sounds Friday. In addition to the two categories above, the vaccine will also be offered as a basic vaccination for healthcare workers living or working in the Brussels Region. The aim is to protect workers in the sector as well as the most vulnerable patients with whom they come into contact at the same time,” says the Joint Community Commission.
For all non-vaccinated Brussels residents
Furthermore, the vaccine will be offered to all Brussels residents over the age of eighteen who have not yet been vaccinated. You can visit the vaccination centers of Anderlecht and Vorst at fixed times, or every day at the vaccination centers Molenbeek and Pachéco. From March 1, it will also be possible to make an appointment via the Bru-Vax platform, or via the call center on 02/214.19.19.
Our country has ordered 510,000 doses, as previously known. With this delivery, up to 170,000 people can be vaccinated, because the need for a booster is also taken into account.